Overview

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

Status:
Withdrawn

Trial end date:
2019-05-16

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see if patients treated with both regional chemotherapy using the HAI pump and intravenous chemotherapy are able to have their liver tumors removed surgically (resected), versus treatment with only intravenous chemotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Collaborators:

Oregon Health and Science University
Queens Cancer Center of Queens Hospital
The Cleveland Clinic
Washington University School of Medicine

Treatments:

Antibodies, Monoclonal
Camptothecin
Dexamethasone
Floxuridine
Fluorouracil
Irinotecan
Leucovorin
Panitumumab